|
Cutena, Inc. (CUTR) DCF -Bewertung
US | Healthcare | Medical - Devices | NASDAQ
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Cutera, Inc. (CUTR) Bundle
Bewerten Sie die finanzielle Aussichten von Cutena, Inc. (CUTR) wie ein Experte! Dieser (CUTR) DCF-Taschenrechner bietet Ihnen vorgefüllte Finanzdaten und die Flexibilität, das Umsatzwachstum, die WACC, die Gewinnmargen und andere kritische Annahmen zu ändern, um sich an Ihren Projektionen zu übereinstimmen.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 181.7 | 147.7 | 231.3 | 252.4 | 212.4 | 228.9 | 246.7 | 265.9 | 286.7 | 309.0 |
| Revenue Growth, % | 0 | -18.73 | 56.6 | 9.14 | -15.86 | 7.79 | 7.79 | 7.79 | 7.79 | 7.79 |
| EBITDA | -10.5 | -16.9 | .1 | -65.2 | -140.9 | -50.1 | -54.0 | -58.2 | -62.7 | -67.6 |
| EBITDA, % | -5.79 | -11.44 | 0.02507891 | -25.84 | -66.37 | -21.88 | -21.88 | -21.88 | -21.88 | -21.88 |
| Depreciation | 4.5 | 6.5 | 5.5 | 8.5 | 8.6 | 7.6 | 8.2 | 8.8 | 9.5 | 10.3 |
| Depreciation, % | 2.46 | 4.41 | 2.38 | 3.36 | 4.04 | 3.33 | 3.33 | 3.33 | 3.33 | 3.33 |
| EBIT | -15.0 | -23.4 | -5.4 | -73.7 | -149.5 | -57.7 | -62.2 | -67.0 | -72.3 | -77.9 |
| EBIT, % | -8.24 | -15.85 | -2.35 | -29.2 | -70.41 | -25.21 | -25.21 | -25.21 | -25.21 | -25.21 |
| Total Cash | 33.9 | 47.0 | 164.2 | 317.3 | 143.6 | 132.4 | 142.7 | 153.8 | 165.8 | 178.7 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 21.6 | 22.0 | 31.4 | 45.6 | 49.4 | 37.4 | 40.3 | 43.4 | 46.8 | 50.5 |
| Account Receivables, % | 11.86 | 14.87 | 13.6 | 18.05 | 23.27 | 16.33 | 16.33 | 16.33 | 16.33 | 16.33 |
| Inventories | 33.9 | 28.5 | 39.5 | 63.6 | 62.6 | 50.2 | 54.2 | 58.4 | 62.9 | 67.8 |
| Inventories, % | 18.67 | 19.3 | 17.08 | 25.21 | 29.48 | 21.95 | 21.95 | 21.95 | 21.95 | 21.95 |
| Accounts Payable | 12.7 | 6.7 | 7.9 | 33.7 | 19.8 | 17.2 | 18.6 | 20.0 | 21.6 | 23.2 |
| Accounts Payable, % | 6.98 | 4.53 | 3.41 | 13.37 | 9.34 | 7.52 | 7.52 | 7.52 | 7.52 | 7.52 |
| Capital Expenditure | -1.0 | -1.3 | -1.0 | -22.7 | -33.0 | -12.1 | -13.0 | -14.0 | -15.1 | -16.3 |
| Capital Expenditure, % | -0.54537 | -0.86604 | -0.43888 | -8.99 | -15.54 | -5.28 | -5.28 | -5.28 | -5.28 | -5.28 |
| Tax Rate, % | -0.95103 | -0.95103 | -0.95103 | -0.95103 | -0.95103 | -0.95103 | -0.95103 | -0.95103 | -0.95103 | -0.95103 |
| EBITAT | -15.1 | -23.9 | -3.3 | -75.2 | -150.9 | -53.2 | -57.3 | -61.8 | -66.6 | -71.8 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -54.4 | -19.6 | -18.1 | -101.8 | -192.1 | -35.9 | -67.6 | -72.9 | -78.6 | -84.7 |
| WACC, % | 4.13 | 4.13 | 2.58 | 4.13 | 4.13 | 3.82 | 3.82 | 3.82 | 3.82 | 3.82 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -300.3 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -86 | |||||||||
| Terminal Value | -4,741 | |||||||||
| Present Terminal Value | -3,930 | |||||||||
| Enterprise Value | -4,230 | |||||||||
| Net Debt | 288 | |||||||||
| Equity Value | -4,519 | |||||||||
| Diluted Shares Outstanding, MM | 20 | |||||||||
| Equity Value Per Share | -227.23 |
What You Will Get
- Editable Excel Template: A fully customizable Excel-based DCF Calculator featuring pre-filled real CUTR financials.
- Real-World Data: Historical data and forward-looking estimates (as indicated in the yellow cells).
- Forecast Flexibility: Adjust forecast assumptions such as revenue growth, EBITDA %, and WACC.
- Automatic Calculations: Instantly observe the effects of your inputs on Cutera’s valuation.
- Professional Tool: Designed for investors, CFOs, consultants, and financial analysts.
- User-Friendly Design: Organized for clarity and ease of use, complete with step-by-step instructions.
Key Features
- Real-Life CUTR Data: Pre-filled with Cutera’s historical financials and forward-looking projections.
- Fully Customizable Inputs: Adjust revenue growth, margins, WACC, tax rates, and capital expenditures.
- Dynamic Valuation Model: Automatic updates to Net Present Value (NPV) and intrinsic value based on your inputs.
- Scenario Testing: Create multiple forecast scenarios to analyze different valuation outcomes.
- User-Friendly Design: Simple, structured, and designed for professionals and beginners alike.
How It Works
- Step 1: Download the Excel file.
- Step 2: Review pre-entered Cutera, Inc. (CUTR) data (historical and projected).
- Step 3: Adjust key assumptions (yellow cells) based on your analysis.
- Step 4: View automatic recalculations for Cutera, Inc. (CUTR)’s intrinsic value.
- Step 5: Use the outputs for investment decisions or reporting.
Why Choose the Cutera, Inc. (CUTR) Calculator?
- Accuracy: Utilizes real Cutera financials for precise data insights.
- Flexibility: Allows users to easily test and adjust inputs as needed.
- Time-Saving: Avoid the complexity of creating a DCF model from the ground up.
- Professional-Grade: Crafted with the precision and usability expected at the CFO level.
- User-Friendly: Intuitive design makes it accessible for users without extensive financial modeling skills.
Who Should Use Cutera, Inc. (CUTR)?
- Investors: Gain insights and make informed decisions with advanced valuation tools tailored for Cutera, Inc. (CUTR).
- Financial Analysts: Streamline your analysis with customizable models specifically designed for the healthcare sector.
- Consultants: Efficiently modify presentations and reports to showcase Cutera, Inc. (CUTR) to your clients.
- Finance Enthusiasts: Enhance your knowledge of the medical technology market through practical examples related to Cutera, Inc. (CUTR).
- Educators and Students: Utilize this resource as a hands-on learning tool in courses focused on finance and healthcare investments.
What the Template Contains
- Pre-Filled DCF Model: Cutera, Inc.’s (CUTR) financial data preloaded for immediate use.
- WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
- Financial Ratios: Evaluate Cutera, Inc.’s (CUTR) profitability, leverage, and efficiency.
- Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
- Financial Statements: Annual and quarterly reports to support detailed analysis.
- Interactive Dashboard: Easily visualize key valuation metrics and results.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.